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ABSTRACT
Neurodegeneration with brain iron accumulation (NBIA) is a complex group of hereditary 
progressive neurodegenerative diseases characterized by deposition of iron in the 
basal ganglia. Twelve genetic forms of this disorder have been identified in previous 
studies. Though they have different inheritance mechanisms all are usually associated 
with abnormal brain MRI findings. One of NBIA types is an X-linked disorder known 
as Beta-propeller Protein Associated Neurodegeneration (BPAN). Herein we describe 
the case of a 4-year-old girl with 2 episodes of febrile seizures, a brain MRI showing 
nonspecific hyperintense signal in the dentate nucleus area, and delays in language and 
communication development. Her diagnosis was made based on a genetic evaluation 
where exome sequencing revealed a mutation in the position chrX:48.933.022 region 
of the WDR45 gene. The literature describes different clinical presentations for BPAN, 
each with a different prognosis, suggesting a wide range of possible symptoms of 
BPAN, including mild cognitive delay and even epileptic encephalopathy (EE).
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INTRODUCTION
Neurodegeneration with brain iron accumulation (NBIA) is a group of 
hereditary neurodegenerative diseases characterized by iron deposition in 
the basal ganglia1. NBIA has heterogenous clinical manifestation, but often 
presents with movement disorders such as parkinsonism and dystonia. 
Brain magnetic resonance imaging (MRI) of patients with these conditions 
usually shows abnormal findings. To date, twelve NBI syndromes have been 
identified, with inheritance patters including autosomal dominant, recessive, 
and as identified in a recent study, X-linked1-4.
Kruer and coworkers (2012) described a novel type of NBIA manifesting as 
intellectual disability in early childhood1,5. The clinical condition remains stable 
in the second and third decades of life, before entering a phase of progressive 
neurological and cognitive decline1,5,6. Brain MRI findings associates with 
this syndrome include iron accumulation specifically in the substantia nigra, 
in addition to global cerebral atrophy1,7.
Due to its clinical course, this disease was originally named Static 
Encephalopathy of childhood with Neurodegeneration in Adulthood (SENDA)1. 
Further studies showed that the condition was caused by a heterozygous 
mutation in the Xp11.23 region of the WDR45 gene1. Since this gene encodes 
a protein associated with autophagy, the name of the condition was changed 
to Beta-propeller Protein Associated Neurodegeneration (BPAN)1,3,8.
Herein we report the case of a female Brazilian patient harboring a mutation 
in the WDR45 gene whose first clinical manifestations were febrile seizures 
and language delay.
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CASE REPORT
The patient was a 4-year-old female, born to 
healthy and non-consanguineous parents, presenting 
language delay.
She was born by cesarean delivery after an 
uneventful pregnancy, with normal anthropometric 
measurements at birth. Developmental milestones 
were reported to be normal although language delay 
was present (spoke her first words at 7 months, with 
no further improvements).
The patient presented two episodes of febrile 
seizures: at 17 months and at 2 years and 2 months. 
After her second febrile seizure, a brain MRI showed 
nonspecific hyperintensity in the dentate nucleus area 
(Figure 1). Language delay was later confirmed by a 
speech therapist and misdiagnosed as speech apraxia.
Figure 1: Observe nonspecific hypersignal in the dentate 
nucleus area on patient’s Brain MRI (white arrow).
The patient underwent comprehensive clinical 
assessments, but no specific diagnosis was established. 
The possibility of an autism spectrum disorder was 
considered, but ultimately discarded due to preservation 
of social skills and lack of typical autism symptoms.
Subsequently, the patient was referred for 
genetic evaluation. Whole exome sequencing (WES) 
identified an intronic mutation in the WDR45 gene 
(c.830 + 1G > A) confirming the diagnosis of NBIA 
type 5, an X-linked NBIA subtype of the disorder.
The patient has since received rehabilitation 
treatment, but her language is limited to simple words: 
yes, no, “mama” (mother) and “vovó” (grandmother). 
She is currently enrolled in regular school, but is 
not at the same academic level as her classmates 
and has shown no improvement in the language. 
She has no motor deficits, and has shown no clinical 
deterioration and no further seizures.
DISCUSSION
According to the literature, the presentation of 
BPAN is characterized by developmental delayed, 
especially in language skills, followed by a period of 
stability and then a progressive decline with symptoms 
of neurodegeneration1-15. Many of the patients do not 
have an early MRI, as was observed in the present 
case, possibly because they are not suspected of 
having metabolic or genetic disorders.
In this case report, the patient’s first MRI 
occurred after her second episode of febrile seizure. 
The investigation started due to the abnormal finding 
associated to her speech underdevelopment. Autism 
spectrum disorder was considered but soon discarded 
since the patient engaged in social interaction and did 
not meet other the clinical criteria for this condition. 
She is now under clinical observation, with no signs of 
neurological deterioration. Previous studies suggest 
that patients harboring mutations in the WDR45 gene 
usually show global neurological decline after the 
second decade of life11.
There is no accurate epidemiological data on 
NBIA syndromes5. Gregory and colleagues (2004) 
estimated a population prevalence of 1-3/1.000.000, 
assuming low rates of misdiagnosis and missed 
cases. BPAN would account for an estimated 1% 
to 2% of these cases1,12.
In 2016, Yuri A Zarate et al. reported a familial 
case of BPAN, supporting the existence of inherited 
variants and hemizygous germline variants which are 
non-lethal in males13. They described a 20-year-old 
boy with MRI’s abnormalities and deletions in the 
WDR45 gene. His mother, sister and father were 
also tested, and the gene was present in the women. 
The boy was more severely affected than his relatives, 
presenting with epilepsy, global developmental delay 
and totally dependence12. Therefore, even though in 
our case the parents had no genetic mutations, it is 
important for parents to be tested to detect gonadal 
and germline mosaicism. A healthy woman might 
carry the gene and be more likely to pass on the 
mutation to her male children, resulting in a more 
severe debilitating condition.
The present findings can also be compared to those 
of Kyoto Takano et al., who described a 4-year-old male 
patient. The boy had remarkable developmental delay, 
non-syndromic epileptic encephalopathy (EE), and MRI 
evidence of a mild brain atrophy. He was born at 40 weeks 
and 1 day after an uneventful pregnancy, to unrelated 
parents with no family history of neurodevelopment 
disorders. His developmental delay was evident from 
an early age, but no abnormalities were observed on 
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initial MRI scans. Similar to our patient, he developed 
seizures at 14 months; however, these were not 
accompanied by fever, and were refractory to multiple 
antiepileptic drugs. The boy eventually showed global 
neurological deterioration, and was diagnosed with 
EE, a group of disorders characterized by intractable 
seizures that lead to sever cognitive deterioration. 
Moreover, he showed a de novo intronic hemizygous 
mutation in the WDR45 gene, identical to our patient, 
but with more severe neurological impairment14.
While many patients have been described and 
diagnosed in the adulthood, Michelle Long et al. 
reported on an 18-year-old girl with a WDR45 mutation 
(c.251A > G, p.Asp84Gly) and pathognomonic MRI 
findings, but only mild cognitive delay and complete 
independency15. In other words, mutations in the 
WDR45 gene can result in different phenotypes.
These data demonstrate that neurodegenerative 
diseases can vary in terms of severity and clinical 
presentation at any age. It is therefore reasonable 
to suggest that children like our patient should have 
regular clinical monitoring to better predict the onset 
of the severe decline stage and verify whether early 
intervention can be effective.
Based on our case report and literature review, 
we suggest that BPAN be included as a differential 
diagnosis for neurological disorders in children with 
development delay who present with febrile seizures, 
or even seizures unaccompanied by fever.
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